About the Master

Eric Reiman is Executive Director and CEO of Banner Alzheimer’s Institute.

About the e-Class

More and more biomarkers are now used in the clinical diagnosis of Alzheimer's disease, which improves the accuracy of AD diagnosis and provides the possibility for the disease’s early prevention and early diagnosis. However, we need to further explore more stable, reliable and specific biomarkers and their detection methods.